Literature DB >> 8110843

Structure and analysis of the 5' flanking region of the human interleukin-2 gene.

E Jankevics1, G Makarenkova, A Tsimanis, E Grens.   

Abstract

To investigate the structural and functional organization of the human interleukin-2 locus, the nucleotide sequence of 9339 bp of the 5' flanking region of this gene has been determined. Computer search analysis reveals five stretches with a high degree of homology between the human and mouse 5' flanking sequence, including a very distant 5' region. In this region additional binding sites for potential transcription factors were found that are identical to known regulatory sequences. The possible roles of these putative regulatory elements in the interleukin-2 gene regulation remain to be proven. The 5' end of the sequence contains almost full-length LINE element. LINE consensus open reading frames ORF1 and ORF2 in the reported sequence are interrupted by insertions, deletions or in-frame nonsense mutations. Comparative analysis of the ratio of codon changes that result in amino acid replacement to those that are silent revealed a high silent mutation frequency throughout the consensus ORF1 3' end, suggesting that this region is probably under selection for protein function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110843     DOI: 10.1016/0167-4781(94)90045-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction.

Authors:  A Avots; A Hoffmeyer; E Flory; A Cimanis; U R Rapp; E Serfling
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

2.  Touring Ensembl: a practical guide to genome browsing.

Authors:  Giulietta M Spudich; Xosé M Fernández-Suárez
Journal:  BMC Genomics       Date:  2010-05-11       Impact factor: 3.969

3.  A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.

Authors:  J Zhao; G J Freeman; G S Gray; L M Nadler; L H Glimcher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.